Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details - Stock option activity)

v3.24.1.1.u2
Stockholders' Equity (Details - Stock option activity) - Equity Option [Member] - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of options outstanding, Beginning balance 513,874  
Weighted average exercise price outstanding, Beginning balance $ 4.05  
Weighted average remaining contractual life   7 years 3 months
Aggregate intrinsic value options outstanding, Beginning balance $ 0  
Number of options, Granted 112,500  
Weighted average exercise price, Granted $ 1.50  
Number of options, Exercised 0  
Weighted average exercise price, Exercised $ 0  
Number of options, Cancelled or forfeited 0  
Weighted average exercise price, Cancelled or forfeited $ 0  
Number of options outstanding, Ending balance 626,374 513,874
Weighted average exercise price outstanding, Ending balance $ 3.60 $ 4.05
Weighted average remaining contractual life 7 years 6 months  
Aggregate intrinsic value options outstanding, Ending balance $ 0 $ 0
Number of options, Vested 541,999  
Weighted average exercise price, Vested $ 3.92  
Weighted average remaining contractual life, Vested 7 years 1 month 24 days  
Number of options, Exercisable 541,999  
Weighted average exercise price, Exercisable $ 3.92  
Weighted average remaining contractual life, Exercisable 7 years 1 month 24 days